Timing of Cardio-Kidney Protection With SGLT2 Inhibitors: Insights From 4 Large-Scale Placebo-Controlled Outcome Trials. Neuen BL, Claggett BL, Perkovic V, Jardine M, et al. Circulation 2024;150:343-345.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Neuen BL, Claggett BL, Perkovic V, Jardine M, et al. Timing of Cardio-Kidney Protection With SGLT2 Inhibitors: Insights From 4 Large-Scale Placebo-Controlled Outcome Trials. Circulation 2024;150:343-345.
PMID: 38733145